AI assistant
Merck & Co., Inc. — Director's Dealing 2019
May 8, 2019
284_dirs_2019-05-07_0511ceb0-6fb3-4894-b0dd-c55b235ab1ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-05-03
Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-04 | Common Stock | M | 692.0000 | $0.0000 | Acquired | 2045.8290 | Direct |
| 2019-05-04 | Common Stock | F | 238.0000 | $80.0000 | Disposed | 1807.8290 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-03 | Stock Option (right to buy) | $80.0000 | A | 11291.0000 | Acquired | 2029-05-02 | Common Stock (11291.0000) | Direct |
| 2019-05-04 | Restricted Stock Unit | $ | M | 692.0000 | Disposed | 2021-05-04 | Common Stock (692.0000) | Direct |
| 2019-05-03 | Restricted Stock Unit | $ | A | 1500.0000 | Acquired | 2022-05-03 | Common Stock (1500.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.